Back
Stoke Therapeutics Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20
STOK
Stoke Therapeutics
Last Price:
11.57
Seasonality Move:
-1.15%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...Stoke Therapeutics Price Quote
$11.57
+0.26 (+2.3%)
(Updated: November 21, 2024 at 1:20 PM ET)
Stoke Therapeutics Key Stats
Sell
20
Stoke Therapeutics (STOK)
is a Sell
Day range:
$11.08 - $11.64
52-week range:
$3.77 - $17.58
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
36.07
P/B ratio:
2.71%
Volume:
265.1K
Avg. volume:
468.8K
1-year change:
171.22%
Market cap:
$629.2M
Revenue:
$8.8M
EPS:
$-2.1
How Much Does Stoke Therapeutics Make?
-
How Much Are Stoke Therapeutics's Sales Annually?
STOK Revenues are $8.8M -
How Much Profit Does Stoke Therapeutics's Make A Year?
STOK net income is -$104.7M
Is Stoke Therapeutics Growing As A Company?
-
What Is Stoke Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.48% -
What Is Stoke Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Stoke Therapeutics Stock Price Performance
-
Did Stoke Therapeutics Stock Go Up Last Month?
Stoke Therapeutics share price went down by -13% last month -
Did STOK's Share Price Rise Over The Last Year?
STOK share price rose by 171.22% over the past 1 year
What Is Stoke Therapeutics 52-Week High & Low?
-
What Is Stoke Therapeutics’s 52-Week High Share Price?
Stoke Therapeutics has traded as high as $17.58 over the past 52 weeks -
What Is Stoke Therapeutics’s 52-Week Low Share Price?
Stoke Therapeutics has traded as low as $3.77 over the past 52 weeks
Stoke Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Stoke Therapeutics?
-
How Much Debt Does Stoke Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Stoke Therapeutics Have?
Cash and short term investments quarterly total is $239.2M -
What Is Stoke Therapeutics’s Book Value Per Share?
Book value per share is 4.38
Is Stoke Therapeutics Cash Flow Positive?
-
What Is STOK Cash Flow From Operations?
Cash flow from operations (TTM) is -$84.3M -
What Is Stoke Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $137.9M -
What Is Stoke Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$93.5M
Stoke Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
STOK return on invested capital is -55.64% -
What Is Stoke Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -41.37% -
What Is STOK Return On Equity?
ROE is a measure of profitability and is -55.64%
Stoke Therapeutics Earnings Date & Stock Price
-
What Is Stoke Therapeutics's Stock Price Today?
A single share of STOK can be purchased today for 11.31 -
What Is Stoke Therapeutics’s Stock Symbol?
Stoke Therapeutics trades on the nasdaq under the ticker symbol: STOK -
When Is Stoke Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Stoke Therapeutics is scheduled on March 25, 2025 -
When Is STOK's next ex-dividend date?
Stoke Therapeutics's next ex-dividend date is November 21, 2024 -
How To Buy Stoke Therapeutics Stock?
You can buy Stoke Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Stoke Therapeutics Competitors
-
Who Are Stoke Therapeutics's Competitors?
Below is a list of companies who compete with Stoke Therapeutics or are related in some way:
Stoke Therapeutics Dividend Yield
-
What Is STOK Dividend Yield?
Stoke Therapeutics’s dividend yield currently is 0% -
What Is Stoke Therapeutics’s Payout Ratio?
Stoke Therapeutics’s payout ratio is 0% -
When Did Stoke Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 21, 2024 -
What Is Stoke Therapeutics’s Dividend Per Share?
Stoke Therapeutics pays a dividend of $0.00 per share
Stoke Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 13.23% |
| Revenue: | 47.94% | 35.94% |
Analyst Recommendations
| Buy Recommendations: | 6 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 22.29 |
| Upside from Last Price: | 97.04% |